DE60300414D1 - Feste Dosierungsform mit Desmopressin - Google Patents

Feste Dosierungsform mit Desmopressin

Info

Publication number
DE60300414D1
DE60300414D1 DE60300414T DE60300414T DE60300414D1 DE 60300414 D1 DE60300414 D1 DE 60300414D1 DE 60300414 T DE60300414 T DE 60300414T DE 60300414 T DE60300414 T DE 60300414T DE 60300414 D1 DE60300414 D1 DE 60300414D1
Authority
DE
Germany
Prior art keywords
desmopressin
solid dosage
dosage form
diluent
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60300414T
Other languages
English (en)
Other versions
DE60300414T2 (de
Inventor
Hakan Lomryd
Helena Nicklasson
Lars-Erik Olsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32981781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60300414(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring BV filed Critical Ferring BV
Application granted granted Critical
Publication of DE60300414D1 publication Critical patent/DE60300414D1/de
Publication of DE60300414T2 publication Critical patent/DE60300414T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
DE60300414T 2003-04-30 2003-04-30 Feste Dosierungsform mit Desmopressin Expired - Lifetime DE60300414T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03009659A EP1473029B1 (de) 2003-04-30 2003-04-30 Feste Dosierungsform mit Desmopressin

Publications (2)

Publication Number Publication Date
DE60300414D1 true DE60300414D1 (de) 2005-04-28
DE60300414T2 DE60300414T2 (de) 2006-05-11

Family

ID=32981781

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60300414T Expired - Lifetime DE60300414T2 (de) 2003-04-30 2003-04-30 Feste Dosierungsform mit Desmopressin

Country Status (18)

Country Link
EP (2) EP1473029B1 (de)
JP (1) JP4597124B2 (de)
KR (1) KR100766455B1 (de)
CN (1) CN100438857C (de)
AT (1) ATE291419T1 (de)
AU (1) AU2004233596B2 (de)
CA (1) CA2486833C (de)
DE (1) DE60300414T2 (de)
DK (1) DK1473029T3 (de)
ES (1) ES2236640T3 (de)
MX (1) MXPA05011591A (de)
NO (1) NO331205B1 (de)
NZ (1) NZ542653A (de)
PL (1) PL211799B1 (de)
PT (1) PT1473029E (de)
RU (1) RU2290945C2 (de)
SI (1) SI1473029T1 (de)
WO (1) WO2004096181A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DK1500390T3 (da) * 2003-07-25 2005-09-19 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
CN102423485B (zh) * 2011-12-08 2014-08-06 赵联华 含有醋酸去氨加压素的口服组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
JP2001139461A (ja) * 1999-11-10 2001-05-22 Ohta Pharmaceut Co Ltd 速崩壊性錠剤
JP4596586B2 (ja) * 2000-01-27 2010-12-08 旭化成ケミカルズ株式会社 トレハロース粒子
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.

Also Published As

Publication number Publication date
CN100438857C (zh) 2008-12-03
JP4597124B2 (ja) 2010-12-15
DE60300414T2 (de) 2006-05-11
RU2005131494A (ru) 2006-03-20
CA2486833C (en) 2005-08-02
AU2004233596B2 (en) 2010-04-08
PT1473029E (pt) 2005-05-31
EP1473029A1 (de) 2004-11-03
ES2236640T3 (es) 2005-07-16
KR20060012592A (ko) 2006-02-08
EP1670439A2 (de) 2006-06-21
DK1473029T3 (da) 2005-04-18
KR100766455B1 (ko) 2007-10-15
AU2004233596A1 (en) 2004-11-11
JP2006524663A (ja) 2006-11-02
ATE291419T1 (de) 2005-04-15
PL379703A1 (pl) 2006-11-13
NZ542653A (en) 2008-04-30
CN1780608A (zh) 2006-05-31
MXPA05011591A (es) 2005-12-15
SI1473029T1 (en) 2005-10-31
EP1473029B1 (de) 2005-03-23
NO20055016L (no) 2005-10-27
RU2290945C2 (ru) 2007-01-10
NO331205B1 (no) 2011-10-31
WO2004096181A2 (en) 2004-11-11
WO2004096181A3 (en) 2004-12-23
PL211799B1 (pl) 2012-06-29
CA2486833A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
NO20051896L (no) Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav
SG146608A1 (en) Rapid dissolution formulation of a calcium receptor-active compound
WO2002101412A3 (en) Spray freeze-dried compositions
IL159843A0 (en) Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
CA2489407A1 (en) Lasofoxifene tablet and its coating
EA201190012A1 (ru) Твердые лекарственные формы бендамустина
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
WO2002087546A3 (en) Method for manufacturing a low dose pharmaceutical composition
WO2004096823A3 (en) Novel ketolide derivatives
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
NO20055016L (no) Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav
MY134340A (en) Pharmaceutical formulation having a masked taste and method for the production thereof
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
TW200640472A (en) Solid pharmaceutical composition comprising telithromycin
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
JP2007297309A (ja) 経口固形製剤
WO2005020876A3 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof
WO2004000864A3 (en) 11-c-substituted ketolides
ATE504555T1 (de) Phenylbenzoesäure-derivate, herstellungsverfahren dafür, pharmazeutische zusammensetzungen damit und therapeutische verwendungen damit
BR0304619A (pt) Formulação farmacêutica com gosto dissimulado e seu processo de preparo
NO20013901L (no) Umettede kolestanderivater og deres anvendelse for fremstilling av meioseregulerende medikamenter

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings